Proteinuria converts hepatic heparan sulfate to an effective proprotein convertase subtilisin kexin type 9 enzyme binding partner
Open Access
- 17 February 2021
- journal article
- research article
- Published by Elsevier BV in Kidney International
- Vol. 99 (6), 1369-1381
- https://doi.org/10.1016/j.kint.2021.01.023
Abstract
No abstract availableFunding Information
- Agence Nationale de la Recherche
This publication has 81 references indexed in Scilit:
- Effect of heparin and low-molecular weight heparin on serum potassium and sodium levelsJournal of Pharmacology and Pharmacotherapeutics, 2011
- Lipoprotein lipase deficiency in chronic kidney disease is accompanied by down-regulation of endothelial GPIHBP1 expressionClinical and Experimental Nephrology, 2011
- Dyslipidemia Associated with Chronic Kidney DiseaseThe Open Cardiovascular Medicine Journal, 2011
- Identification of Tubular Heparan Sulfate as a Docking Platform for the Alternative Complement Component Properdin in Proteinuric Renal DiseaseOnline Journal of Public Health Informatics, 2011
- Type 2 diabetes in mice induces hepatic overexpression of sulfatase 2, a novel factor that suppresses uptake of remnant lipoproteinsJournal of Hepatology, 2010
- Syndecan-1 is the primary heparan sulfate proteoglycan mediating hepatic clearance of triglyceride-rich lipoproteins in miceJCI Insight, 2009
- Adriamycin Alters Glomerular Endothelium to Induce ProteinuriaJournal of the American Society of Nephrology, 2009
- Molecular basis for LDL receptor recognition by PCSK9Proceedings of the National Academy of Sciences of the United States of America, 2008
- Self-Association of Human PCSK9 Correlates with Its LDLR-Degrading ActivityBiochemistry, 2008
- Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9Proceedings of the National Academy of Sciences of the United States of America, 2005